1Sud T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332(6 159):78
2Dasgupta A,Chow L,Tso G,et al.Stability of NT-proB-NP in serum specimens collected in Becton Dickinson Vacutainer (SST)tubes[J].Clin Chem,2003,49 (6 Pt 1):958
3Yandle TG.Biochemistry of natriuretic peptides[J].J Intern Med,1994,235(6):561
4Nakagawa O,Ogawa Y,Itoh H,et al.Evidence for brain natriuretic peptide as an “emergency”cardiac hormone against ventricular overload[J].J Clin Invest,1995,96(3):1 280
5CowieMR,Mendez GF.BNP and congestive heart failure[J].Prog Cardiovasc Dis,2002,44 (4):293
6Remme WJ,Swedberg K.Task force for the diagnosis and treatment of chronic heart failure,et al.Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22(17):1527
7Ryan TJ,Antman EM,Brooks NH,et al.1999 update:ACC/AHA guidelines for the management of patients with acute myocardial infarction.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)[J].J Am Coll Cardiol,1999,34(3):890
8Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med,2002,347(3):161
9Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction[J].Circulation,1997,96(2):509
10Jortani SA,Prabhu SD,Valdes RJ.Strategies for developing biomarkers of heart failure[J].Clin Chem,2004,50 (2):265
3Steg PG.Joubin L,McCord Let al.B-Type Natriuretic peptide and echocardiographic determination of ejection fractionin the diagnosis of congestive heart hilum in patients with acute dyspnea[J].Chest,2005,128(1):21-29.
4HARRISON A,MORRISON LK,KRISHNASwAMY P,et al.B·type natriuretic peptide(BN P)predicts future cardiacevents in pa tienta presenting to emergency department with dyspncu[J].Ann Emerg Med,2002,39(2):131-138.
5Stein BC,Levin RI.Natriuretic peptides:Physiology,ther-apeutic potential,and risk st ratification in ischemic heart disease[J].Am Heart J,1998,1(55):914-915.
6Me GrathMF. Kuroskide Bold ML. de Bo IdA J. The endo trine function of the heart [ J ]. Trends Endocfinol Metab, 2005,16(10) :469 -477.
7Samak M J, Katz R, Stehman-Breen CO, et al. Cystatin concentration as a risk factor for heart failure in older adults [J]. Ann Intern Med, 2005,142:497- 505.
8Berger R;Huelsman M;Strecker K.B-type natriuretic peptide predicts sudden death in patients with chronic heart failure[J],2002(20).
9Seino Y;Ogawa A;Yanmashita T.Application of NT-proBNP and BNP measurements in cardiac care:a more discerning nmrker fol the detection and evalution of hearffailure,2004.
10Tsehope C;KasnerM;Westerm annD.The role of NT-proBN-Pinthe diagnostic of isolated diastolic dysfunction correlation wi 山 echocardiographic andinvasive measuerments,2005.
